{
    "2018-08-23": [
        [
            {
                "time": "2018-03-15",
                "original_text": "The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, FPI, FIZZ, ACAD, TTPH and ABBV",
                "features": {
                    "keywords": [
                        "Klein Law Firm",
                        "Class Actions",
                        "Shareholders",
                        "MD",
                        "FPI",
                        "FIZZ",
                        "ACAD",
                        "TTPH",
                        "ABBV"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "legal",
                        "investments"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "AbbVie Posts Positive Data on Elagolix for Uterine Fibroids",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Elagolix",
                        "Positive Data",
                        "Uterine Fibroids"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Bristol-Myers: FDA To Review SBLA For Empliciti With Pomalidomide, Dexamethasone",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "FDA",
                        "SBLA",
                        "Empliciti",
                        "Pomalidomide",
                        "Dexamethasone"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "regulatory"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}